MG132, NH4Cl, Cycloheximide (CHX) and Actinomycin D (ActD) were purchased from MedChemExpress (Monmouth Junction, NJ). Chloroquine was from Cell Signaling Technology (Danvers, MA). Polyinosinic-polycytidylic acid [poly(I:C)] was from Sigma-Aldrich (St. Louis, MO).
Nh4cl
NH4Cl is a chemical compound that consists of ammonium and chloride ions. It is a white, crystalline solid that is commonly used as a laboratory reagent and in various industrial applications.
Lab products found in correlation
3 protocols using nh4cl
Antibody Characterization for Crucian Carp Immunity
MG132, NH4Cl, Cycloheximide (CHX) and Actinomycin D (ActD) were purchased from MedChemExpress (Monmouth Junction, NJ). Chloroquine was from Cell Signaling Technology (Danvers, MA). Polyinosinic-polycytidylic acid [poly(I:C)] was from Sigma-Aldrich (St. Louis, MO).
Amyloid-beta Peptide Utilization in Antiviral Studies
Synthetic Aβ1–42 peptides were obtained from Anaspec (Fremont, CA. USA). Dried peptides were solubilized in 150 mM NaCl prior to experimentation. Aβ1–42 was used at 30 µg/mL concentration for the viral life-cycle experiment and 20 µg/mL for the antiviral activity test or pull-down experiment.
Pirodavir was purchased from Biochempartner (Shanghai, China), and NH4Cl was bought from MedChemExpress (USA). Stock solutions of pirodavir (10 mM) and NH4Cl (100 mM) were prepared in dimethyl sulfoxide (Sigma–Aldrich, Carlsbad, CA, USA), respectively. RBV stock solutions (2 mg/mL) were dissolved in a cell culture medium.
Antibody Characterization and Cellular Treatments
MG132, chloroquine (CQ), 3-MA, NH4Cl, and Z-VAD-FMK were purchased from MedChemExpress (New Jersey, USA). Lipofectamine2000 transfection reagent (11668019) was purchased from Thermo Fisher Scientific (Massachusetts, USA). jetPRIME and jetPEI-Macrophage were purchased from Polyplus Transfection (Strasbourg, France).
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!